TITLE

Molecular characterization of drug-resistant and drug-sensitive Aspergillus isolates causing infectious keratitis

AUTHOR(S)
Nayak, Niranjan; Satpathy, Gita; Prasad, Sujata; Titiyal, Jeewan S.; M.Pandey, R; Vajpayee, Rasik B.
PUB. DATE
September 2011
SOURCE
Indian Journal of Ophthalmology;Sep2011, Vol. 59 Issue 5, p373
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
To study the susceptibilities of Aspergillus species against amphotericin B in infectious keratitis and to find out if drug resistance had any association with the molecular characteristics of the fungi. Materials and Methods: One hundred and sixty Aspergillus isolates from the corneal scrapings of patients with keratitis were tested for susceptibilities to amphotericin B by broth microdilution method. These included Aspergillus fl avus (64 isolates), A. fumigatus (43) and A. niger (53). Fungal DNA was extracted by glass bead vertexing technique. Polymerase chain reaction (PCR) assay was standardized and used to amplify the 28S rRNA gene. Single-stranded conformational polymorphism (SSCP) of the PCR product was performed by the standard protocol. Results: Of the 160 isolates, 84 (52.5%) showed low minimum inhibitory concentration (MIC) values (≤ 1.56 μg/ml) and were designated as amphotercin B-sensitive. Similarly, 76 (47.5%) had high MICs (≥ 3.12 μg/ml) and were categorized as amphotericin B-resistant. MIC50 and MIC90 values ranged between 3.12-6.25 μg/ml and 3.12-12.5 μg/ml respectively. A. fl avus and A. niger showed higher MIC50 and MIC90 values than A. fumigatus. The SSCP patt ern exhibited three extra bands (150 bp, 200 bp and 250 bp each) in addition to the 260 bp amplicon. Strains (lanes 1 and 7) lacking the 150 bp band showed low MIC values (≤ 1.56 μg/ml). Conclusion: A. niger and A. fl avus isolates had higher MICs compared to A. fumigatus, suggesting a high index of suspicion for amphotericin B resistance. PCR-SSCP was a good molecular tool to characterize Aspergillus phenotypes in fungal keratitis.
ACCESSION #
64735828

 

Related Articles

  • IDENTIFICATION OF FUNGAL KERATITIS AGENTS IN THE EAST OF MAZANDARAN AREA BY PCR AND DETERMINATION OF THEIR DRUG SENSITIVITY. Nikpour, Shaghayegh; Omran, Ayatollah Nasrollahi; Omran, Saeid Mahdavi; Karmi, Azar // Jundishapur Journal of Microbiology;2013 Special Edition, p77 

    Introduction and Objectives: Fungal infection causes extensive infective ocular ulcer worldwide and can due to morbidity and blindness. Keratitis is prevalent in tropical and developing countries. For diagnosis and treatment fungal infection is one of the most challenging causes of corneal...

  • A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Hebart, H.; Klingspor, L.; Klingebiel, T.; Loeffler, J.; Tollemar, J.; Ljungman, P.; Wandt, H.; Schaefer-Eckart, K.; Dornbusch, H. J.; Meisner, C.; Engel, C.; Stenger, N.; Mayer, T.; Ringden, O.; Einsele, H. // Bone Marrow Transplantation;Apr2009, Vol. 43 Issue 7, p553 

    We compared the efficacy and safety of empirical plus PCR-based vs empirical liposomal amphotericin B treatment after Allo-SCT. Allo-SCT recipients were randomized to receive either PCR-based preemptive therapy (group A; n=198) or empirical antifungal therapy (group B; n=211) with liposomal...

  • Fonsecaea Pedrosoi: A Rare Etiology in Fungal Keratitis. SANGWAN, JYOTI; LATHWAL, SUMIT; JUYAL, DEEPAK; SHARMA, NEELAM // Journal of Clinical & Diagnostic Research;Oct2013, Vol. 7 Issue 10, p2272 

    Fungal corneal ulcer is common in India due to tropical climate and a large agrarian population that is at risk. Fonsecaea pedrosoi is the most common agent of chromoblastomycosis, a chronic localized fungal infection of the skin and subcutaneous tissues mainly involving lower extremities. We...

  • Antifungal Susceptibility of the Aspergillus Species by Etest and CLSI Reference Methods. Badiee, Parisa; Alborzi, Abdolvahab; Moeini, Mahsa; Haddadi, Pedram; Farshad, Shohreh; Japoni, Aziz; Ziyaeyan, Maziar // Archives of Iranian Medicine (AIM);Jul2012, Vol. 15 Issue 7, p429 

    Background: Because resistance to antifungal drugs is seen in patients, susceptibility testing of these drugs aids in choosing the appropriate drug and respective epidemiology. This study has investigated and compared susceptibility patterns of the Aspergillus species isolated from patients by...

  • Efficacies and Clinical Roles of New Antifungal Agents. Tokimatsu, Issei; Kadota, Jun-ichi // Japanese Journal of Medical Mycology;Sep2006, Vol. 47 Issue 3, p155 

    Micafungin, a new class of the antifungal agent "echinocandin" released in 2002, and voriconazole, a new triazole antifungal agent released in 2005 in Japan have in vitro activities against Aspergillus spp. Results of large-scale clinical trials in Europe and the United States showed...

  • Schizophyllum commune: A New Organism in Eye Infection. Saha, Suman; Sengupta, Jayangshu; Banerjee, Debdulal; Khetan, Archana; Mandal, Santi // Mycopathologia;Apr2013, Vol. 175 Issue 3/4, p357 

    Purpose: We report a case of mycotic keratitis caused by a rare fungus Schizophyllum commune. Methods: Clinical examination, slit-lamp examination, and microbiological evaluation of the corneal ulcer were done, and its treatment outcome was studied. The fungal etiology was established by...

  • Potential synergistic activity of antimycotic substances in combination with human platelets against Aspergillus fumigatus. Perkhofer, Susanne; Trappl, Krista; Nussbaumer, Walter; Dierich, Manfred P.; Lass-Flörl, Cornelia // Journal of Antimicrobial Chemotherapy (JAC);Jun2010, Vol. 65 Issue 6, p1309 

    The article discusses a study which examines the possible synergistic activity of antimycotic substances along with human platelets against Aspergillus fumigatus. For the study, researchers analyzed two clinical Aspergillus fumigatus isolates and four antifungal drugs. They found that human...

  • Caspofungin: A Review of its Use in the Treatment of Fungal Infections. McCormack, Paul L.; Perry, Caroline M. // Drugs;2005, Vol. 65 Issue 14, p2049 

    Caspofungin (Cancidas®) is the first of a new class of antifungal agents, the echinocandins, that inhibit the synthesis of the fungal cell wall component β-(1,3)-D-glucan. Caspofungin is administered once daily by slow intravenous infusion and is used to treat infections caused by Candida...

  • Fungicidal Activity of Azole Antifungal Agents. Majoros, L.; Kardos, G. // Anti-Infective Agents in Medicinal Chemistry;2008, Vol. 7 Issue 2, p118 

    Treatment of invasive fungal infections with fungicidal antifungal agents is desirable in some clinical situations, particularly in the immunocompromised. However, there are a limited number of fungicidal drugs and most have undesirable side effects. Applicability of amphotericin B and its...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics